Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRTS Alpha Tau Medical	$3.14 +2.6%	$3.10	$2.11 ▼ $4.39	$266.34M	0.99	63,373 shs	82,943 shs
ESTA Establishment Labs	$40.00 +2.3%	$40.76	$26.56 ▼ $50.85	$1.16B	0.83	531,579 shs	361,226 shs
MDXG MiMedx Group	$7.03 -2.0%	$6.61	$5.47 ▼ $10.14	$1.04B	1.79	687,618 shs	220,993 shs
PLSE Pulse Biosciences	$16.00 +0.3%	$15.39	$13.77 ▼ $25.00	$1.08B	1.6	173,047 shs	79,347 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRTS Alpha Tau Medical	-1.92%	-10.53%	+2.68%	+2.00%	+40.37%
ESTA Establishment Labs	+3.69%	+1.96%	-8.24%	+6.08%	-11.28%
MDXG MiMedx Group	-0.28%	-1.38%	+7.82%	+6.70%	+10.99%
PLSE Pulse Biosciences	+0.57%	-5.00%	+6.55%	-5.40%	-16.88%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DRTS Alpha Tau Medical	2.5648 of 5 stars	3.5	5.0	0.0	0.9	1.7	0.0
ESTA Establishment Labs	2.1171 of 5 stars	3.4	0.0	0.0	2.6	2.5	0.6
MDXG MiMedx Group	3.2227 of 5 stars	3.5	4.0	0.0	3.2	1.7	0.6
PLSE Pulse Biosciences	3.6803 of 5 stars	3.5	0.0	4.2	1.0	4.2	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DRTS Alpha Tau Medical	3.00	Buy	$9.00	186.62% Upside
ESTA Establishment Labs	2.83	Moderate Buy	$56.50	41.25% Upside
MDXG MiMedx Group	3.00	Buy	$12.00	70.70% Upside
PLSE Pulse Biosciences	3.00	Buy	$22.00	37.50% Upside

Current Analyst Ratings Breakdown

Latest DRTS, ESTA, PLSE, and MDXG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2025	ESTA Establishment Labs	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$60.00
7/31/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$11.00 ➝ $12.00
7/16/2025	ESTA Establishment Labs	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$58.00 ➝ $70.00
7/15/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$11.00
7/9/2025	ESTA Establishment Labs	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$38.00 ➝ $47.00
7/7/2025	PLSE Pulse Biosciences	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$22.00
6/13/2025	ESTA Establishment Labs	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$48.00

(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$1.02 per share	N/A
ESTA Establishment Labs	$166.02M	6.98	N/A	N/A	$0.79 per share	50.63
MDXG MiMedx Group	$348.88M	2.98	$0.32 per share	21.70	$1.46 per share	4.82
PLSE Pulse Biosciences	$700K	1,537.83	N/A	N/A	$1.55 per share	10.32

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DRTS Alpha Tau Medical	-$31.75M	-$0.48	N/A	N/A	N/A	N/A	-51.21%	-38.18%	N/A
ESTA Establishment Labs	-$84.60M	-$3.05	N/A	N/A	N/A	-49.89%	-224.34%	-25.53%	11/6/2025 (Estimated)
MDXG MiMedx Group	$42.42M	$0.21	33.48	21.97	N/A	8.84%	23.03%	17.09%	10/29/2025 (Estimated)
PLSE Pulse Biosciences	-$53.58M	-$1.05	N/A	∞	N/A	N/A	-63.19%	-54.98%	10/29/2025 (Estimated)

Latest DRTS, ESTA, PLSE, and MDXG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	PLSE Pulse Biosciences	-$0.26	-$0.28	-$0.02	-$0.28	$0.50 million	N/A
8/11/2025	Q2 2025	DRTS Alpha Tau Medical	-$0.12	-$0.13	-$0.01	-$0.13	N/A	N/A
8/7/2025	Q2 2025	ESTA Establishment Labs	-$0.54	-$0.57	-$0.03	-$0.57	$50.80 million	$51.30 million
7/30/2025	Q2 2025	MDXG MiMedx Group	$0.06	$0.10	+$0.04	$0.06	$90.79 million	$98.61 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
ESTA Establishment Labs	N/A	N/A	N/A	N/A	N/A
MDXG MiMedx Group	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DRTS Alpha Tau Medical	0.07	10.52	5.81
ESTA Establishment Labs	9.71	2.84	1.67
MDXG MiMedx Group	0.08	4.39	3.90
PLSE Pulse Biosciences	N/A	12.05	12.04

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DRTS Alpha Tau Medical	2.65%
ESTA Establishment Labs	72.91%
MDXG MiMedx Group	79.15%
PLSE Pulse Biosciences	76.95%

Insider Ownership

Company	Insider Ownership
DRTS Alpha Tau Medical	39.50%
ESTA Establishment Labs	11.09%
MDXG MiMedx Group	1.70%
PLSE Pulse Biosciences	71.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DRTS Alpha Tau Medical	80	84.82 million	51.32 million	No Data
ESTA Establishment Labs	1,018	28.97 million	25.76 million	Optionable
MDXG MiMedx Group	870	147.96 million	145.44 million	Optionable
PLSE Pulse Biosciences	140	67.28 million	19.17 million	Optionable

DRTS, ESTA, PLSE, and MDXG Headlines

Recent News About These Companies

Pulse Biosciences (NASDAQ:PLSE) Trading Down 5.2% - Time to Sell?

August 17, 2025 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.1% - What's Next?

August 15, 2025 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Releases Earnings Results

August 14, 2025 | marketbeat.com

Pulse Biosciences Reports Q2 2025 Progress and Results

August 13, 2025 | msn.com

Pulse Biosciences, Inc. (PLSE) Q2 2025 Earnings Call Transcript

August 12, 2025 | seekingalpha.com

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

August 12, 2025 | businesswire.com

Pandora Wealth Inc. Takes Position in Pulse Biosciences, Inc (NASDAQ:PLSE)

August 10, 2025 | marketbeat.com

Pulse Biosciences (PLSE) to Release Earnings on Tuesday

August 6, 2025 | marketbeat.com

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

August 1, 2025 | finance.yahoo.com

Pulse Biosciences (NASDAQ:PLSE) Trading 2% Higher - Should You Buy?

August 1, 2025 | marketbeat.com

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

July 29, 2025 | businesswire.com

Oppenheimer Initiates Coverage of Pulse Biosciences (PLSE) with Outperform Recommendation

July 8, 2025 | msn.com

Insider Purchases Worth US$2.70m See Losses As Pulse Biosciences Market Value Drops To US$1.1b

June 17, 2025 | finance.yahoo.com

Pulse Biosciences, Inc. (NASDAQ:PLSE) CTO Darrin Uecker Sells 15,000 Shares

June 17, 2025 | insidertrades.com

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 23, 2025 | businesswire.com

Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership

May 21, 2025 | uk.finance.yahoo.com

Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript

May 10, 2025 | seekingalpha.com

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

May 6, 2025 | businesswire.com

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

May 2, 2025 | finance.yahoo.com

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 25, 2025 | businesswire.com

Pulse Biosciences (NASDAQ:PLSE) Is In A Strong Position To Grow Its Business

April 24, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

DRTS, ESTA, PLSE, and MDXG Company Descriptions

Alpha Tau Medical NASDAQ:DRTS

$3.14 +0.08 (+2.61%)

Closing price 04:00 PM Eastern

Extended Trading

$3.17 +0.03 (+0.96%)

As of 04:10 PM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Establishment Labs NASDAQ:ESTA

$40.00 +0.91 (+2.33%)

Closing price 04:00 PM Eastern

Extended Trading

$40.01 +0.01 (+0.02%)

As of 06:43 PM Eastern

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

MiMedx Group NASDAQ:MDXG

$7.03 -0.14 (-1.95%)

Closing price 04:00 PM Eastern

Extended Trading

$7.04 +0.01 (+0.14%)

As of 05:51 PM Eastern

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Pulse Biosciences NASDAQ:PLSE

$16.00 +0.05 (+0.31%)

Closing price 04:00 PM Eastern

Extended Trading

$16.07 +0.07 (+0.41%)

As of 04:42 PM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time